RARECast

548 Episoder

1. Crowdsourcing Therapeutic Approaches for an Ultra-Rare Disease

   Publisert: 5.2.2020
2. Delivering Oligonucleotide Therapies to Any Cell Type

   Publisert: 29.1.2020
3. Protalix Looks Beyond Biobetters

   Publisert: 22.1.2020
4. Driving N-of-1 Therapies for Ultra-Rare Disease Patients

   Publisert: 15.1.2020
5. Cutting the Time and Cost of Drug Discovery with MicroOrgans

   Publisert: 8.1.2020
6. Acquisition Combines Two Pipelines for Rare Skin Diseases

   Publisert: 2.1.2020
7. Programming Cells to Produce Neuroprotective Factors to Treat ALS

   Publisert: 26.12.2019
8. Origin's Rapid Path to Seek Approval for Treatment of Ultra-Rare Metabolic Condition

   Publisert: 18.12.2019
9. Developing a Common Language for Rare Diseases

   Publisert: 11.12.2019
10. Why Payers Lag Drug Developers and Regulators in Embracing Real-World Evidence

    Publisert: 4.12.2019
11. How a Brother's Love Is Forging a Path for Customized Therapies for Rare Disease Patients

    Publisert: 27.11.2019
12. Addressing the Barriers to Accessing Experimental Therapies

    Publisert: 20.11.2019
13. A Journey to Advocacy

    Publisert: 13.11.2019
14. Turning Chronic Illness into a Fashion Statement

    Publisert: 6.11.2019
15. Connecting Young Adults with Rare and Chronic Conditions

    Publisert: 30.10.2019
16. Helping Caregivers Care for Themselves

    Publisert: 23.10.2019
17. A Festival of Moving Pictures

    Publisert: 16.10.2019
18. Deep Genomics Boasts an AI First in Drug Discovery

    Publisert: 9.10.2019
19. How to Live with a Disability with Your Mojo Intact

    Publisert: 3.10.2019
20. Why a Big Pharma Exec Embraced Rare Neurological Diseases

    Publisert: 25.9.2019